{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:15:12Z","timestamp":1790262912704,"version":"4.1.0"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Peritoneal metastases (PM) are common in metastatic colorectal cancer (mCRC). We aimed to characterize patients with mCRC and PM from a clinical and molecular perspective using the American Association of Cancer Research Genomics Evidence Neoplasia Information Exchange (GENIE) Biopharma Collaborative (BPC) registry. Patients\u2019 tumor samples underwent targeted next-generation sequencing. Clinical characteristics and treatment outcomes were collected retrospectively. Overall survival (OS) from advanced disease and progression-free survival (PFS) from start of cancer-directed drug regimen were estimated and adjusted for the left truncation bias. A total of 1,281 patients were analyzed, 244 (19%) had PM at time of advanced disease. PM were associated with female sex [OR: 1.67; 95% confidence interval (CI): 1.11\u20132.54; P = 0.014] and higher histologic grade (OR: 1.72; 95% CI: 1.08\u20132.71; P = 0.022), while rectal primary tumors were less frequent in patients with PM (OR: 0.51; 95% CI: 0.29\u20130.88; P &amp;lt; 0.001). APC occurred less frequently in patients with PM (N = 151, 64% vs. N = 788, 79%) while MED12 alterations occurred more frequently in patients with PM (N = 20, 10% vs. N = 32, 4%); differences in MED12 were not significant when restricting to oncogenic and likely oncogenic variants according to OncoKB. Patients with PM had worse OS (HR: 1.45; 95% CI: 1.16\u20131.81) after adjustment for independently significant clinical and genomic predictors. PFS from initiation of first-line treatment did not differ by presence of PM. In conclusion, PM were more frequent in females and right-sided primary tumors. Differences in frequencies of MED12 and APC alterations were identified between patients with and without PM. PM were associated with shorter OS but not with PFS from first-line treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Utilizing the GENIE BPC registry, this study found that PM in patients with colorectal cancer occur more frequently in females and right-sided primary tumors and are associated with worse OS. In addition, we found a lower frequency of APC alterations and a higher frequency in MED12 alterations in patients with PM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0409","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:42:08Z","timestamp":1707385328000},"page":"475-486","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3119-3832","authenticated-orcid":true,"given":"Enrique","family":"Sanz-Garcia","sequence":"first","affiliation":[{"name":"1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre \u2013 University Health Network, Department of Medicine, University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-974X","authenticated-orcid":true,"given":"Samantha","family":"Brown","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2746-5647","authenticated-orcid":true,"given":"Jessica A.","family":"Lavery","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8679-9524","authenticated-orcid":true,"given":"Jessica","family":"Weiss","sequence":"additional","affiliation":[{"name":"1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre \u2013 University Health Network, Department of Medicine, University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2426-0096","authenticated-orcid":true,"given":"Hannah E.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-0426","authenticated-orcid":true,"given":"Ashley","family":"Newcomb","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6015-8390","authenticated-orcid":true,"given":"Asha","family":"Postle","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-7242","authenticated-orcid":true,"given":"Jeremy L.","family":"Warner","sequence":"additional","affiliation":[{"name":"4Vanderbilt-Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-3784","authenticated-orcid":true,"given":"Michele L.","family":"LeNoue-Newton","sequence":"additional","affiliation":[{"name":"4Vanderbilt-Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-6566","authenticated-orcid":true,"given":"Shawn M.","family":"Sweeney","sequence":"additional","affiliation":[{"name":"5American Association of Cancer Research, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0699-0458","authenticated-orcid":true,"given":"Shirin","family":"Pillai","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-1091","authenticated-orcid":true,"given":"Celeste","family":"Yu","sequence":"additional","affiliation":[{"name":"1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre \u2013 University Health Network, Department of Medicine, University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4367-2569","authenticated-orcid":true,"given":"Chelsea","family":"Nichols","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-9738","authenticated-orcid":true,"given":"Brooke","family":"Mastrogiacomo","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-2859","authenticated-orcid":true,"given":"Ritika","family":"Kundra","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0131-4904","authenticated-orcid":true,"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-9797","authenticated-orcid":true,"given":"Kenneth L.","family":"Kehl","sequence":"additional","affiliation":[{"name":"3Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-4313","authenticated-orcid":true,"given":"Gregory J.","family":"Riely","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-5717","authenticated-orcid":true,"given":"Deborah","family":"Schrag","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1769-2688","authenticated-orcid":true,"given":"Anand","family":"Govindarajan","sequence":"additional","affiliation":[{"name":"6Sinai Health System, Toronto, Ontario, Canada."},{"name":"7Department of Surgery, University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-604X","authenticated-orcid":true,"given":"Katherine S.","family":"Panageas","sequence":"additional","affiliation":[{"name":"2Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-2999","authenticated-orcid":true,"given":"Philippe L.","family":"Bedard","sequence":"additional","affiliation":[{"name":"1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre \u2013 University Health Network, Department of Medicine, University of Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"2024022014480692600_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2024022014480692600_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"2024022014480692600_bib3","doi-asserted-by":"crossref","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"key":"2024022014480692600_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"2024022014480692600_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","article-title":"Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States","volume":"21","author":"Turaga","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2024022014480692600_bib6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"2024022014480692600_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","article-title":"Prognostic impact of BRAF and KRAS mutation in patients with colorectal and appendiceal peritoneal metastases scheduled for CRS and HIPEC","volume":"27","author":"Graf","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2024022014480692600_bib8","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.21037\/jgo-20-136","article-title":"Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review","volume":"12","author":"Lund-Andersen","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"2024022014480692600_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical sequencing defines the genomic landscape of metastatic colorectal cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"key":"2024022014480692600_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7314\/APJCP.2016.17.2.539","article-title":"Value of KRAS, BRAF, and PIK3CA mutations and survival benefit from systemic chemotherapy in colorectal peritoneal carcinomatosis","volume":"17","author":"Sasaki","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024022014480692600_bib11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1080\/0284186X.2018.1487581","article-title":"The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern","volume":"57","author":"Prasanna","year":"2018","journal-title":"Acta Oncol"},{"key":"2024022014480692600_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/bjc.2016.161","article-title":"Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers","volume":"115","author":"Kim","year":"2016","journal-title":"Br J Cancer"},{"key":"2024022014480692600_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov"},{"key":"2024022014480692600_bib14","doi-asserted-by":"crossref","first-page":"e2117547","DOI":"10.1001\/jamanetworkopen.2021.17547","article-title":"Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non\u2013small cell lung or colorectal cancer","volume":"4","author":"Kehl","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2024022014480692600_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaoncol.2021.5153","article-title":"Implications of selection bias due to delayed study entry in clinical genomic studies","volume":"8","author":"Brown","year":"2022","journal-title":"JAMA Oncol"},{"key":"2024022014480692600_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"2024022014480692600_bib17","doi-asserted-by":"crossref","first-page":"btac796","DOI":"10.1093\/bioinformatics\/btac796","article-title":"A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package","volume":"39","author":"Lavery","year":"2023","journal-title":"Bioinformatics"},{"key":"2024022014480692600_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2011","journal-title":"J Clin Oncol"},{"key":"2024022014480692600_bib19","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1002\/bjs.10788","article-title":"Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases","volume":"105","author":"Ubink","year":"2018","journal-title":"Br J Surg"},{"key":"2024022014480692600_bib20","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"key":"2024022014480692600_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1066896916664990","article-title":"Mucinous and signet ring cell differentiation affect patterns of metastasis in colorectal carcinoma and influence survival","volume":"25","author":"Kermanshahi","year":"2017","journal-title":"Int J Surg Pathol"},{"key":"2024022014480692600_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2024022014480692600_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrm.2017.115","article-title":"Transcription regulation by the Mediator complex","volume":"19","author":"Soutourina","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2024022014480692600_bib24","first-page":"663","article-title":"MED12 is recurrently mutated in Middle Eastern colorectal cancer","volume":"67","author":"Siraj","year":"2018","journal-title":"Gut"},{"key":"2024022014480692600_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2012.10.035","article-title":"MED12 controls the response to multiple cancer drugs through regulation of TGF-\u03b2 receptor signaling","volume":"151","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"2024022014480692600_bib26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jso.25899","article-title":"Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma","volume":"121","author":"Stein","year":"2020","journal-title":"J Surg Oncol"},{"key":"2024022014480692600_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2024022014480692600_bib28","doi-asserted-by":"crossref","first-page":"djw332","DOI":"10.1093\/jnci\/djw332","article-title":"Multiple roles of APC and its therapeutic implications in colorectal cancer","volume":"109","author":"Zhang","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2024022014480692600_bib29","doi-asserted-by":"crossref","first-page":"18900","DOI":"10.1038\/s41598-020-75844-6","article-title":"The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden","volume":"10","author":"Hallam","year":"2020","journal-title":"Sci Rep"},{"key":"2024022014480692600_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s43032-019-00084-7","article-title":"Introduction of somatic mutation in MED12 induces Wnt4\/\u03b2-catenin and disrupts autophagy in human uterine myometrial cell","volume":"27","author":"El Andaloussi","year":"2020","journal-title":"Reprod Sci"},{"key":"2024022014480692600_bib31","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1074\/jbc.M602696200","article-title":"Mediator is a transducer of Wnt\/beta-catenin signaling","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"2024022014480692600_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12885-015-1276-z","article-title":"A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer","volume":"15","author":"Kawazoe","year":"2015","journal-title":"BMC Cancer"},{"key":"2024022014480692600_bib33","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1245\/s10434-021-11045-3","article-title":"Microsatellite and RAS\/RAF mutational status as prognostic factors in colorectal peritoneal metastases treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"29","author":"Tonello","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2024022014480692600_bib34","first-page":"3946875","article-title":"Prognostic value of KRAS gene mutation on survival of patients with peritoneal metastases of colorectal adenocarcinoma","volume":"2021","author":"Diez-Alonso","year":"2021","journal-title":"Int J Surg Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0409\/3413921\/crc-23-0409.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/2\/475\/3417197\/crc-23-0409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/2\/475\/3417197\/crc-23-0409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T09:49:09Z","timestamp":1708422549000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/2\/475\/734683\/Genomic-Characterization-and-Clinical-Outcomes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0409","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.25248643.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248640.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248634.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248637.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248649.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248634","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248655.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248646.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248652.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248640","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248652","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248628","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248646","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248658","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248658.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248631","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248643","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248655","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248631.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248637","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248628.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.25248649","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7081861.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7081861","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}